Organization: Medicago

Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics

The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.

The Short Report, March 25, 2020: Tech CEOs implore Ottawa to protect their industry, the NGEN supercluster commits $50M to scaling up production of supplies to fight COVID-19, and more

The Canadian Institutes of Health Research launched a new COVID-19 funding opportunity for operating grants called the “COVID-19 Clinical Epidemiology Research Rapid Response.” The application deadline is this Friday, March 27, and successful applicants will be notified of the decision on April 1. The competition description emphasizes the viruses “many unknown epidemiological parameters, particularly with respect…